Effect of Topical Fluorouracil Cream on Photodamage: Secondary Analysis of a Randomized Clinical Trial | Dermatology | JAMA Dermatology | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.206.177.17. Please contact the publisher to request reinstatement.
1.
Riahi  RR, Bush  AE, Cohen  PR.  Topical retinoids: therapeutic mechanisms in the treatment of photodamaged skin.  Am J Clin Dermatol. 2016;17(3):265-276.PubMedGoogle ScholarCrossref
2.
Han  A, Chien  AL, Kang  S.  Photoaging.  Dermatol Clin. 2014;32(3):291-299, vii. vii.PubMedGoogle ScholarCrossref
3.
Yaar  M, Gilchrest  BA.  Photoageing: mechanism, prevention and therapy.  Br J Dermatol. 2007;157(5):874-887.PubMedGoogle ScholarCrossref
4.
Uitto  J, Fazio  MJ, Olsen  DR.  Molecular mechanisms of cutaneous aging: age-associated connective tissue alterations in the dermis.  J Am Acad Dermatol. 1989;21(3, pt 2):614-622.PubMedGoogle ScholarCrossref
5.
Bernstein  EF, Brown  DB, Schwartz  MD, Kaidbey  K, Ksenzenko  SM.  The polyhydroxy acid gluconolactone protects against ultraviolet radiation in an in vitro model of cutaneous photoaging.  Dermatol Surg. 2004;30(2, pt 1):189-195.PubMedGoogle Scholar
6.
Levin  AA, Sturzenbecker  LJ, Kazmer  S,  et al.  9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXR alpha.  Nature. 1992;355(6358):359-361.PubMedGoogle ScholarCrossref
7.
Guimarães  CO, Miot  HA, Bagatin  E.  Five percent 5-fluorouracil in a cream or for superficial peels in the treatment of advanced photoaging of the forearms: a randomized comparative study.  Dermatol Surg. 2014;40(6):610-617.PubMedGoogle Scholar
8.
Ceilley  RI.  Mechanisms of action of topical 5-fluorouracil: review and implications for the treatment of dermatological disorders.  J Dermatolog Treat. 2012;23(2):83-89.PubMedGoogle ScholarCrossref
9.
Beer  K, Kellner  E, Beer  J.  Cosmeceuticals for rejuvenation.  Facial Plast Surg. 2009;25(5):285-289.PubMedGoogle ScholarCrossref
10.
Sturm  HM, Scott  H.  Treatment of actinic keratoses with topical 5-fluorouracil.  J Med Assoc Ga. 1968;57(5):205-209.PubMedGoogle Scholar
11.
Falkson  G, Schulz  EJ.  Skin changes in patients treated with 5-fluorouracil.  Br J Dermatol. 1962;74:229-236.PubMedGoogle ScholarCrossref
12.
Sachs  DL, Kang  S, Hammerberg  C,  et al.  Topical fluorouracil for actinic keratoses and photoaging: a clinical and molecular analysis.  Arch Dermatol. 2009;145(6):659-666.PubMedGoogle ScholarCrossref
13.
Longley  DB, Harkin  DP, Johnston  PG.  5-fluorouracil: mechanisms of action and clinical strategies.  Nat Rev Cancer. 2003;3(5):330-338.PubMedGoogle ScholarCrossref
14.
Griffiths  CE, Wang  TS, Hamilton  TA, Voorhees  JJ, Ellis  CN.  A photonumeric scale for the assessment of cutaneous photodamage.  Arch Dermatol. 1992;128(3):347-351.PubMedGoogle ScholarCrossref
15.
Donofrio  L, Carruthers  J, Hardas  B,  et al.  Development and validation of a photonumeric scale for evaluation of infraorbital hollows.  Dermatol Surg. 2016;42(suppl 1):S251-S258.PubMedGoogle ScholarCrossref
16.
Carruthers  A, Donofrio  L, Hardas  B,  et al.  Development and validation of a photonumeric scale for evaluation of static horizontal forehead lines.  Dermatol Surg. 2016;42(suppl 1):S243-S250.PubMedGoogle ScholarCrossref
17.
Carruthers  J, Donofrio  L, Hardas  B,  et al.  Development and validation of a photonumeric scale for evaluation of facial fine lines.  Dermatol Surg. 2016;42(suppl 1):S227-S234.PubMedGoogle ScholarCrossref
18.
Donofrio  L, Carruthers  A, Hardas  B,  et al.  Development and validation of a photonumeric scale for evaluation of facial skin texture.  Dermatol Surg. 2016;42(suppl 1):S219-S226.PubMedGoogle ScholarCrossref
19.
Sykes  JM, Carruthers  A, Hardas  B,  et al.  Development and validation of a photonumeric scale for assessment of chin retrusion.  Dermatol Surg. 2016;42(suppl 1):S211-S218.PubMedGoogle ScholarCrossref
20.
Carruthers  J, Jones  D, Hardas  B,  et al.  Development and validation of a photonumeric scale for evaluation of volume deficit of the temple.  Dermatol Surg. 2016;42(suppl 1):S203-S210.PubMedGoogle ScholarCrossref
21.
Jones  D, Donofrio  L, Hardas  B,  et al.  Development and validation of a photonumeric scale for evaluation of volume deficit of the hand.  Dermatol Surg. 2016;42(suppl 1):S195-S202.PubMedGoogle ScholarCrossref
22.
World Medical Association.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.  JAMA. 2013;310(20):2191-2194. doi:10.1001/jama.2013.281053PubMedGoogle ScholarCrossref
23.
Carruthers  A, Carruthers  J, Hardas  B,  et al.  A validated grading scale for crow’s feet.  Dermatol Surg. 2008;34(suppl 2):S173-S178.PubMedGoogle Scholar
24.
Carruthers  A, Carruthers  J, Hardas  B,  et al.  A validated grading scale for marionette lines.  Dermatol Surg. 2008;34(suppl 2):S167-S172.PubMedGoogle Scholar
25.
Donner  A, Klar  N.  The statistical analysis of kappa statistics in multiple samples.  J Clin Epidemiol. 1996;49(9):1053-1058.PubMedGoogle ScholarCrossref
26.
Landis  JR, Koch  GG.  The measurement of observer agreement for categorical data.  Biometrics. 1977;33(1):159-174.PubMedGoogle ScholarCrossref
Original Investigation
November 2017

Effect of Topical Fluorouracil Cream on Photodamage: Secondary Analysis of a Randomized Clinical Trial

Kaveri Korgavkar, MD1; Kachiu C. Lee, MD, MPH1; Martin A. Weinstock, MD, PhD1,2; et al for the Veterans Affairs Keratinocyte Carcinoma Chemoprevention (VAKCC) Trial Group
Author Affiliations
  • 1Department of Dermatology, Brown University, Providence, Rhode Island
  • 2Dermatoepidemiology Unit, Veterans Affairs Medical Center, Providence, Rhode Island
JAMA Dermatol. 2017;153(11):1142-1146. doi:10.1001/jamadermatol.2017.2578
Key Points

Question  What is the effect of a standard course of topical fluorouracil cream on photoaging?

Findings  In this ad hoc secondary analysis of the Veterans Affairs Keratinocyte Carcinoma ChemopreventionTrial including primarily elderly men with severe sun damage, no statistically significant change in photodamage was observed with a standard course of topical fluorouracil cream using 4 validated photonumeric scales at any time point from baseline to 18 months.

Meaning  A standard course of topical fluorouracil did not result in detectable improvement of photodamage.

Abstract

Importance  Photoaging, which is premature skin aging caused by long-term UV exposure, is of aesthetic concern to many patients.

Objective  To investigate the effect of topical fluorouracil, 5%, cream on photoaging using validated photonumeric scales.

Design, Setting, and Participants  The Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial was a randomized clinical trial of 932 US veterans with a recent history of 2 or more keratinocyte carcinomas performed from September 30, 2011, through June 30, 2014, to assess the chemopreventive effects of a standard course of topical fluorouracil. Photographs were taken at baseline and at numerous time points for up to 4 years. In our secondary analysis, 2 independent dermatologists graded these photographs using 4 validated photonumeric scales. A total of 3042 photographs from 281 participants randomized to apply topical fluorouracil or placebo were evaluated at baseline, 6 months, 12 months, and 18 months using 4 photonumeric scales (Griffiths scale, Allergan forehead lines scale, melomental folds scale, and crow’s feet scale). Data analysis was performed from November 1, 2016, to January 1, 2017.

Interventions  Participants were randomized to apply topical fluorouracil, 5%, cream or a vehicle control cream to the face and ears twice daily for 2 to 4 weeks for a total of 28 to 56 doses.

Main Outcomes and Measures  Effect of a standard course of fluorouracil on the extent of photodamage as measured using 4 photonumeric scales.

Results  The study population was predominantly male (274 [97.5%]) and white (281 [100%]), with a mean (SD) age of 71.5 (0.57) years. No statistically significant changes were found in photodamage between baseline and 6 months (Griffiths scale: χ2 = 0.01, P = .93; Allergan forehead lines scale: χ2 = 0.18, P = .67; melomental fold scale: χ2 = 0.03, P = .87; crow’s feet scale: χ2 = 2.41, P = .12), 12 months (Griffiths scale: χ2 = 1.39, P = .24; Allergan forehead lines scale: χ2 = 0.64, P = .43; melomental fold scale: χ2 = 0.12, P = .73; crow’s feet scale: χ2 = 1.07, P = .30), and 18 months (Griffiths scale: χ2 = 3.11, P = .08; Allergan forehead lines scale: χ2 = 0.89, P = .34; melomental fold scale: χ2 = 1.64, P = .20; crow’s feet scale: χ2 = 0.46, P = .50).

Conclusions and Relevance  This study did not demonstrate improvement in photoaging with a standard course of topical fluorouracil, 5%, cream, a finding that may be attributable to a true lack of effect in photodamage or limitations of the photonumeric scales in capturing the effect. The development of photonumeric scales that include manifestations of photoaging other than rhytids, such as lentigines, hyperpigmentation, and telangiectasias, should be considered.

Trial Registration  clinicaltrials.gov Identifier: NCT00847912

×